Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.60 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.60 |
| ▸ | HTR2A | P28223 | 1/20 | 0.60 |
| ▸ | HTR2C | P28335 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | HRH1 | P35367 | 1/20 | 0.60 |
| ▸ | DRD3 | P35462 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8811133 | 0.89 | CA2 (0.54) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL275821 | 0.88 | — | — | |
| SCHEMBL8811451 | 0.87 | CA2 (0.52) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL277259 | 0.85 | CA2 (0.55) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL2352379 | 0.82 | CA2 (0.58) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL20490025 | 0.82 | CHRM1 (0.48) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL28210380 | 0.80 | HDAC1 (0.46) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL7701880 | 0.78 | CA2 (0.59) | GRIK1SLC1A2SLC1A1GRIK2CA2 | |
| SCHEMBL919412 | 0.78 | CA2 (0.59) | GRIK1SLC1A2SLC1A1GRIK2CA2 | |
| SCHEMBL919763 | 0.78 | CA2 (0.59) | GRIK1SLC1A2SLC1A1GRIK2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117440961-A | Nucleoside medicine for treating or preventing coronavirus infection and application thereof | 北京沐华生物科技有限责任公司 | 2024-01-23 | — | — | CN | claimed |
| WO-2023207942-A1 | NUCLEOSIDE DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTION, AND USE THEREOF | 北京沐华生物科技有限责任公司 | 2023-11-02 | — | — | WO | claimed |
| US-20230338409-A1 | NUCLEOSIDE DRUGS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION AND THEIR USES | MIRACURE BIOTECHNOLOGY LTD (CN) | 2023-10-26 | — | — | US | claimed |
| CN-117440961-A | Nucleoside medicine for treating or preventing coronavirus infection and application thereof | 北京沐华生物科技有限责任公司 | 2024-01-23 | — | — | CN | disclosed |
| WO-2023207942-A1 | NUCLEOSIDE DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTION, AND USE THEREOF | 北京沐华生物科技有限责任公司 | 2023-11-02 | — | — | WO | disclosed |
| US-20230338409-A1 | NUCLEOSIDE DRUGS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION AND THEIR USES | MIRACURE BIOTECHNOLOGY LTD (CN) | 2023-10-26 | — | — | US | disclosed |
| EP-3372581-B1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | DAIKIN IND LTD (JP) | 2021-06-23 | — | — | EP | disclosed |
| US-10894770-B2 | Fullerene derivative and n-type semiconductor material | DAIKIN INDUSTRIES, LTD. (JP) | 2021-01-19 | — | — | US | disclosed |
| US-20180282274-A1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | DAIKIN INDUSTRIES, LTD. (JP) | 2018-10-04 | — | — | US | disclosed |
| EP-3372581-A1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | Daikin Industries, Ltd. (JP) | 2018-09-12 | — | — | EP | disclosed |
| CN-104955926-B | For improving the lubricant compositions for including epoxide compound of fluoropolymer sealant compatibility | 巴斯夫欧洲公司 | 2018-06-22 | — | — | CN | disclosed |
| WO-2014184071-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014184070-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| EP-2420493-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | Nissan Chemical Industries, Ltd. (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2336104-A1 | ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE | Nissan Chemical Industries, Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| US-4261987-A | ANTICONVULSANTS | GEROT PHARMAZEUTIKA GESELLSCHAFT M.B.H. (AT) | 1981-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894770-B2 | Fullerene derivative and n-type semiconductor material | SUN2, NES, L1CAM | HDAC1 4044/4885HDAC2 3787/4885CHRM1 51/4885 |
| US-20180282274-A1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | SUN2, NES, L1CAM | HDAC1 4044/4885HDAC2 3787/4885CHRM1 51/4885 |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | CBR3, CBR1, HDHD5 | HDAC1 1679/4885HDAC2 2358/4885CHRM1 75/4885 |
| US-20230338409-A1 | NUCLEOSIDE DRUGS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION AND THEIR USES | PNP, MTAP, TYMP | HDAC1 3090/4885HDAC2 2884/4885CHRM1 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.